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Carotid Arteries
Fishbein I, Alferiev I, Bakay M, et al. Circulation 2008;117:2096-103.
Conclusion: Sustained release of gene vectors is possible through
reversible immobilization of adenovirus vectors on bare-metal surfaces of
vascular stents.
Summary: Polymer-coated stents facilitate local drug delivery to the
vasculature and have proven efficacious in preventing in-stent restenosis.
There are, however, concerns about the inflammatory effects of polymer
coatings and late outcomes of drug-eluting stents. The authors investigated
whether adenoviral vectors could be delivered from bare metal surfaces of
stents using a synthetic complex for reversible vector binding. Three com-
ponents of a gene vector-binding complex were synthesized: (1) a polyal-
lylamine bisphosphonate with latent thiol groups (PABT), (2) a polyethyl-
enimine (PEI) with pyridyldithio groups for amplification of attachments
sites [PEI (PVT)], and (3) a bifunctional amine-reactive and thiol-reactive
cross-linker with labile ester bond (HL).
TheHL-modified adenovirus attached to PABT/PEI(PDT)-treated steel
surfaces and demonstrated in vitro sustained release for 30 days. They also
demonstrated localized green fluorescent protein expression in rat arterial
smooth muscle cell cultures. This expression was not sensitive to inhibition by
neutralizing antiadenovirus antibodies or inactivation after storage at 37°C. In
rat carotid studies, steel stents configured with PABT/PEI(PDT)/HL-teth-
ered adenoviral vectors demonstrated site-specific arterial adenovirus green
fluorescent protein expression and adenovirus-luciferase transgene activity by
optical imaging. Adenovirus encoding inducible nitric oxide synthase delivered
by a carotid stent resulted in significant inhibition of restenosis.
Comment: This study investigated local delivery of gene therapy from
bare-metal stent surfaces using reversible chemical attachment of vectors to
the bare-metal stents. Adenovirus vectors on the surfaces of the stents
demonstrated 1-month release kinetics and site-specific transduction of
target cell types in vitro and in vivo in this rat model. Deployment of stents
configured with 109 adenovirus vectors encoded for inducible nitric oxide
synthase resulted in significant reduction of in-stent restenosis. It appears
that the concept of gene-eluting stents is valid andmay provide a mechanism
of local and systemic delivery of gene products by the vasculature.
Post-Traumatic Ulnar Artery Thrombosis: Outcome of Arterial Recon-
struction Using Reverse Interpositional Vein Grafting at 2 Years
Minimum Follow-Up
Chloros GD, Lucas RM, Li Z, et al. J Hand Surg [Am] 2008;33:932-40.
Conclusion: Successful arterial reconstruction of patients with symp-
tomatic post-traumatic ulnar artery thrombosis (UAT) improves function in
microvascular physiology, decreases symptoms, and positively affects quality
of life.
Summary: The authors report follow-up of use of interposition vein
grafts to treat symptomatic patients with UAT. Patients included in this
retrospective study had to have arteriographically proven UAT treated with
excision and reversed interposition veins grafts, no known collagen vascular
disease, coagulopathy, or peripheral vascular disease, and a minimum fol-
low-up of 24 months. There were 13 patients (13 hands) identified and
evaluated before surgery and at final follow-up using health-related quality
of life outcome instruments. These included the McCabe cold sensitivity
scale, the McGill visual analog pain scale, the Levine symptom and function
scale, and the Wake Forest University symptoms scale incorporating pain,
numbness, and cold intolerance. Microvascular perfusion testing was done
using laser Doppler perfusion imaging. Cold stress tests were also per-
formed. Results of cold testing were compared with 28 healthy controls.
Graft patency was assessed by Allen testing or Doppler ultrasound imaging,
or both.
At the final follow-up, 10 of 13 grafts (77%) were patent. In patients
with patent grafts, the Levine symptom scale, the McGill visual analog pain
scale, and the McCabe cold sensitivity severity score all uniformly improved
postoperatively. Cold testing responses also improved at final follow-up and
were not different from those of normal controls. Changes in Levine
function scale, Wake Forest University scale, and laser Doppler perfusion
were not significant. In the three patients with nonpatent grafts, two
complained of pain, numbness, and cold sensitivity, whereas the other had
minimal symptoms.
Comments: Although the number of patients is small, this is actually a
relatively large series with prolonged follow-up of an unusual condition
infrequently treated by operation. Of particular interest is improvement inquality of life noted in these patients and the normalization of their physio-
logic response to cold testing. Interposition vein grafting of the distal ulnar
artery is relatively straightforward if the thrombosed segment does not
involve the digital vessels. In such cases the saphenous vein at the ankle is an
appropriate conduit. The operation, of course, is considerably more techni-
cally demanding when digital arteries must be reimplanted into the saphe-
nous vein graft. This may be done through individual anastomoses of the
digital arteries to the saphenous vein graft, or more commonly in our
experience, incorporation as a patch graft of the portion of the thrombosed
ulnar artery from which the digital arteries originate onto a longitudinally
oriented venotomy in the saphenous vein graft.
High Absolute Risk and Predictors of Venous and Arterial Thrombo-
embolic Events in Patients With Nephrotic Syndrome: Results from a
Large Retrospective Cohort Study
Mahmoodi BK, tenKateMK,Waanders F, et al. Circulation 2008;117:224-30.
Conclusion:The ratio of proteinuria to serum albumin predicts venous
thromboembolism (VTE) in patients with nephrotic syndrome. Estimated
glomerular filtration rate and classic risk factors for atherosclerosis predict
arterial thromboembolism (ATE).
Summary: An increased risk of VTE and ATE has been observed for
50 years in patients with nephrotic syndrome. Such data are based on small
studies with short-term follow-up. Absolute risks of either VTE or ATE are
not available. In this single-center retrospective study, the authors sought to
assess the absolute risk of symptomatic VTE and ATE and to identify
predictive factors in a large cohort of patients with nephrotic syndrome. The
study enrolled 298 consecutive patients (59% men) with nephrotic syn-
drome. Their mean age was 42  18 years. Mean follow-up was 10  9
years. Proteinuria 3.5 g/d was used to identify nephrotic syndrome.
Patients were classified according to underlying histologic lesions account-
ing for their nephrotic syndrome. Symptomatic venous or arterial thrombo-
embolic events were the primary outcome events recorded.
Annual incidences were 1.48% (95% confidence interval [CI], 1.07-
1.99) for ATE and 1.02% (95% CI, 0.68-1.46) for VTE. During the first 6
months, these rates were 5.52% for ATE and 9.85% for VTE. Whereas
proteinuria and serum albumin levels tended to be related to VTE, only the
predictive value of the ratio of protein to serum albumin was significant
(hazard ratio, 5.6; 95% CI, 1.2-26.2; P  .03). Neither, serum albumin
levels or the degree of proteinuria were significantly related to ATE. Prior
ATE, estimated glomerular filtration rate, sex, age, hypertension, diabetes
mellitus, and smoking all predicted ATE (P  .02).
Comment: This study provides the first assessment of absolute risk of
symptomatic VTE and ATE in patients with nephrotic syndrome. Estimates
of VTE are significantly higher than the estimated age- and sex-weighted
absolute risk of the general population. The risk of VTE was excessively high
in the first 6 months of observation, and factors influencing the risk of VTE
and ATE in patients with nephrotic syndrome are not the same. Patients
with nephrotic syndromemay benefit from VTE prophylaxis during this first
6 months of their illness.
Color Doppler Ultrasonography in Occlusive Diseases of the Brachio-
cephalic and Proximal Subclavian Arteries
Yurdakul M, Tola M, Uslu OS. J Ultrasound Med 2008;27:1065-70.
Conclusion:Color duplex ultrasound (DU) imaging is highly accurate
for diagnosing stenoses and occlusions of the brachiocephalic and proximal
subclavian arteries.
Summary: Little information is available regarding the accuracy of
color DU imaging in diagnosing stenoses and occlusions of the brachioce-
phalic and proximal subclavian arteries. In addition, it is widely perceived
that examinations of the brachiocephalic and proximal subclavian arteries are
technically difficult and frequently provide inadequate diagnostic informa-
tion. The authors of this study sought to investigate the capability of color
DU imaging for examining the brachiocephalic and proximal subclavian
arteries and to determine accuracy in diagnosis of occlusive disease of those
arteries. Two groups of patients were studied. The first group was a feasibil-
ity group and was used to determine whether brachiocephalic and subclavian
origins could be seen. The second group included patients with occlusive
disease who underwent both color DU imaging and digital subtraction
angiography, and the two modalities were compared.
In the feasibility study, the origins of 42 of 50 brachiocephalic arteries
(84%) and 48 of 50 right subclavian arteries (96%) and 25 of 50 left
subclavian arteries (50%) could be visualized by color DU imaging. In the
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